You’ve been scrolling through forums, reading about the latest weight loss breakthroughs, and now you’re staring at two names that sound like they belong in a sci-fi movie: retatrutide and tirzepatide. Maybe you’ve even seen a dosage chart and felt your eyes glaze over. It’s a common frustration—you want to understand which option might work for you, but the numbers and acronyms feel like a foreign language. The good news is that these medications are more similar than you think, and once you break down the dosage logic, the whole picture gets a lot clearer. Let’s walk through this together, like we’re comparing notes over coffee.

What Exactly Are Retatrutide and Tirzepatide?

Before we dive into the chart, let’s get the basics straight. Both retatrutide and tirzepatide belong to a class of drugs called GLP-1 receptor agonists, but they’re not identical twins—they’re more like cousins with different specialties. Tirzepatide, which you might know by its brand name Mounjaro or Zepbound, works by mimicking two hormones: GLP-1 and GIP. This dual-action helps lower blood sugar and slows digestion, which keeps you feeling full longer. Retatrutide, a newer player still in clinical trials, takes it a step further by targeting three receptors: GLP-1, GIP, and glucagon. That third hormone, glucagon, ramps up energy burning, which makes retatrutide a potential powerhouse for weight loss. Think of tirzepatide as a well-tuned sedan and retatrutide as a sports car with an extra turbo boost.

The key difference lies in how they’re dosed. Because they work on different receptor combinations, the starting doses, titration schedules, and maximum amounts vary. This isn’t about one being “better” across the board—it’s about matching the right tool to your body’s response. Dosage charts exist to guide you safely through the ramp-up period, preventing nasty side effects like nausea or vomiting that can happen if you jump in too fast.

Why Dosage Matters More Than You Think

Imagine you’re learning to swim. You wouldn’t jump into the deep end on day one, right? That’s exactly how these medications work. Your body needs time to adjust to the new hormonal signals. Starting at a low dose—usually 2.5 mg per week for tirzepatide and around 1 mg for retatrutide in trials—gives your system a gentle nudge. Over several weeks, you’ll increase the dose in small steps, a process called titration. This isn’t arbitrary; it’s designed to minimize side effects while maximizing effectiveness. The chart you’ll see below isn’t a cheat sheet—it’s a roadmap for your journey.

Another reason dosage varies is individual response. Some people feel strong appetite suppression at the lowest dose, while others need to climb higher. Your weight, metabolism, and even your diet play a role. That’s why you’ll never see a one-size-fits-all number. Instead, the chart shows a range, and your healthcare provider will adjust based on how you’re feeling. Think of it as a conversation between you and your body, with the chart as your translator.

Retatrutide vs Tirzepatide Dosage Chart: A Side-by-Side Look

Here’s where the rubber meets the road. Below is a simplified comparison of typical dosing schedules. Remember, retatrutide is still under investigation, so these numbers are based on clinical trial data, while tirzepatide has FDA-approved guidelines. Always defer to your doctor’s specific instructions.

Tirzepatide Dosage Schedule (Weekly Injection)

  • Weeks 1–4: 2.5 mg
  • Weeks 5–8: 5 mg
  • Weeks 9–12: 7.5 mg
  • Weeks 13–16: 10 mg
  • Weeks 17–20: 12.5 mg
  • Weeks 21+: 15 mg (maximum dose)

Retatrutide Dosage Schedule (Weekly Injection, Based on Trials)

  • Weeks 1–4: 1 mg
  • Weeks 5–8: 2 mg
  • Weeks 9–12: 4 mg
  • Weeks 13–16: 6 mg
  • Weeks 17–20: 8 mg
  • Weeks 21–24: 10 mg
  • Weeks 25+: 12 mg (maximum dose in trials)

Notice the pattern? Both start low and build up slowly over months. Tirzepatide’s increments are 2.5 mg steps, while retatrutide’s are smaller at first (1 mg jumps) but become larger later. The total maximum dose for tirzepatide is 15 mg, while retatrutide caps at 12 mg in current studies. But don’t read too much into the numbers—the real story is the rate of increase. Retatrutide’s triple-action mechanism means it might require a gentler start to avoid overwhelming your system, which is why the early doses are tiny.

Another important note: these are weekly injections, not daily. You pick a day (say, Monday morning) and stick with it. If you miss a dose, most guidelines say you can take it within a few days, but never double up. Consistency is your best friend here.

Practical Tips for Navigating Your Dosage Journey

Now that you’ve seen the chart, let’s talk about how to make it work in real life. First, always pair your injection with a meal or snack to reduce nausea. Think of it like taking a vitamin—food buffers the effect. Second, keep a simple journal. Note your dose, how you felt, and any side effects. This isn’t for show; it helps you and your doctor spot patterns. For example, if you feel extreme fatigue after bumping up to 5 mg of tirzepatide, you might need to stay at that dose an extra week before moving on.

Hydration is another unsung hero. These medications can slow digestion, which might make you feel bloated or constipated. Drinking water throughout the day—aim for 8–10 cups—keeps things moving. And don’t forget protein. When you’re eating less, your body needs quality fuel to preserve muscle. A simple rule: prioritize lean meats, eggs, or plant-based proteins at every meal.

Finally, be patient with the process. The first few weeks might feel like nothing’s happening, especially on low doses. That’s normal. The magic happens during the titration phase, when your body hits its sweet spot. Some people lose weight steadily from week one, while others see a drop only after reaching the higher doses. Neither path is wrong—it’s just your unique biology at work.

Which One Should You Consider?

If you’re trying to decide between the two, the answer depends on your goals and timeline. Tirzepatide is the proven workhorse—it’s been studied in thousands of people, approved for both diabetes and weight loss, and has a predictable track record. It’s a solid choice if you want something with a clear roadmap and fewer unknowns. Retatrutide, on the other hand, is the exciting newcomer. Early trial results show it might lead to greater weight loss—some studies report up to 24% of body weight—but it’s not yet FDA-approved. That means you can only access it through clinical trials or off-label prescriptions, which adds a layer of complexity.

For most people, I’d recommend starting with tirzepatide if you’re looking for something accessible and well-documented. If you’re intrigued by retatrutide’s potential and willing to navigate the trial process, it could be worth discussing with a specialist. But here’s the golden rule: never self-prescribe. These are powerful medications that require medical supervision. A good doctor will review your health history, check your kidney function, and help you choose the right starting dose. They’ll also monitor you for rare but serious side effects, like pancreatitis or thyroid issues.

In the end, the dosage chart is just a tool—a guide to help you and your provider make informed decisions. The real work is listening to your body, staying consistent, and celebrating small victories. Whether you go with retatrutide’s triple punch or tirzepatide’s dual action, you’re taking a step toward better health. And that’s something worth smiling about.